CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signalingSamantha M. Fix, Amir A. Jazaeri, Tamara Griffiths et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 44
172 Overcoming immunosuppressive TGF-β signaling in human ovarian cancer-derived tumor infiltrating lymphocytes via non-viral CRISPR engineeringSamantha M. Fix, Amir A. Jazaeri, Marie‐Andrée Forget et al.|Regular and Young Investigator Award Abstracts|2021Cited by 1